本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aldeyra Therapeutics Inc

0.8998
-0.0060-0.66%
盘后:0.8900-0.0098-1.09%19:30 EDT
成交量:145.76万
成交额:129.59万
市值:5,413.45万
市盈率:-2.35
高:0.9100
开:0.8900
低:0.8652
收:0.9058
52周最高:5.93
52周最低:0.8619
股本:6,016.28万
流通股本:4,892.94万
量比:0.57
换手率:2.98%
股息:- -
股息率:- -
每股收益(TTM):-0.3836
每股收益(LYR):-0.5636
净资产收益率:-49.48%
总资产收益率:-22.70%
市净率:1.43
市盈率(LYR):-1.60

数据加载中...

2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/13

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/23

SEC问询函

Form CORRESP - Correspondence
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]